Key thing here is that this isn't envisioning gene

Key thing here is that this isn't envisioning gene therapies, or small molecules, or CED, nothing complex. This sets the stage to test recombinant MANF, now, which we own without a doubt.

I see on Gerald's LinkedIn he's in comms with Dominion. Everyone is going to figure it out and get this ball rolling.